EPO and Guillain-Barre syndrome: These side effects are less likely to be a major issue in GBS because it is anticipated that in this condition use of EPO or other proregenerative agents would only be necessary for a limited/finite period to enhance nerve repair, and patients with preexisting cancer can be excluded from receiving this treatment.